Table 2A.
Outcome measure | Hedges g | 95% CI (p‐value for subgroups) | I 2 | No. of comparisons | No. of articles | No. of animals | Unit |
---|---|---|---|---|---|---|---|
Apoptosis | 0.02 | −0.44 to 0.48 | 11.4% | 10 | 4 | 106 | % apoptotic cells |
Elastin | 0.18 | −0.67 to 1.02 | 71.5% | 12 | 4 | 117 | Concentration, normalized values, % dry weight or % positive cells |
M1 macrophages | 1.85 | 0.83 to 2.88a | 76.8% | 13 | 3 | 106 | Histologic scoring or % positive cells |
M2 macrophages | 2.74 | 1.83 to 3.65a | 64.4% | 13 | 3 | 106 | Histologic scoring or % positive cells |
MMP‐2 | 2.80 | 1.82 to 3.78a | 74.9% | 16 | 4 | 150 | Density/relative expression or normalized values |
Neovascularization – PP vs. PP hybrid |
1.17 1.08 vs. 1.96 |
0.84 to 1.50a NS |
7.5% | 22 | 5 | 176 | Histologic scoring or density/relative expression |
Smooth muscle | 0.20 | −0.42 to 0.82 | 63.2% | 15 | 5 | 147 | Histologic scoring or smooth muscle thickness |
TNF‐α | 0.83 | 0.11 to 1.56a | 68.5% | 13 | 3 | 117 | Concentration or density/relative expression |
Total collagen – PP hybrid vs. biological |
0.17 0.61 vs. −0.25 |
−0.62 to 0.95 NS |
67.8% | 12 | 4 | 117 | Histologic scoring or % dry weight |
Contractility – TA vs. TV |
−0.55 −1.27 vs. 0.05 |
−0.97 to −0.13a p < 0.01 |
34.3% | 17 | 6 | 156 | mN, mN/mm3, or mN/g |
Stiffness – Ewe vs. Macaque – TA vs. TV |
0.68 1.06 vs. 0.14 0.35 vs. 0.88 |
0.20 to 1.17a NS NS |
52.0% | 20 | 6 | 173 | N/mm |
Note: Only subgroup analysis is shown which meets the requirements for subgroup analysis: ≥3 comparisons from ≥3 articles. See Supplementary file 4 for all subgroups per outcome measure, including CI of the above subgroup analysis.
Abbreviations: CI, confidence interval; I 2, heterogeneity; MMP‐2, matrix metalloproteinase‐2; N, number; NS, nonsignificant; PP, polypropylene; TA, transabdominal; TNF‐α, tumor necrosis factor‐alpha; TV, transvaginal; vs., versus.
Significant difference between animals with vaginal implants and control animals.